Terns Pharmaceuticals, Inc.
US ˙ NasdaqGS ˙ US8808811074
DIESES SYMBOL IST NICHT MEHR AKTIV

SecurityTERN / Terns Pharmaceuticals, Inc.
InstitutionProShare Advisors LLC
Latest Disclosed Ownership25,571 shares
Latest Disclosed Value $ 1,348,103
ProShare Advisors LLC reports 30.11% increase in ownership of TERN / Terns Pharmaceuticals, Inc.

On April 24, 2026 - ProShare Advisors LLC filed a 13F-HR form disclosing ownership of 25,571 shares of Terns Pharmaceuticals, Inc. (US:TERN) valued at $1,348,103 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 6, 2026 disclosing 19,654 shares of Terns Pharmaceuticals, Inc.. This represents a change in shares of 30.11% during the quarter. The current value of the position is $1,353,984 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-04-24 2026-03-31 13F TERNS PHARMACEUTICALS COM 880881107 25,571 5,917 30.11 1,348 69.77 0.0020
2026-02-06 2025-12-31 13F TERNS PHARMACEUTICALS COM 880881107 19,654 4,173 26.96 794 584.48 0.0014
2025-11-06 2025-09-30 13F TERNS PHARMACEUTICALS COM 880881107 15,481 -2,608 -14.42 116 73.13 0.0002
2025-08-07 2025-06-30 13F TERNS PHARMACEUTICALS COM 880881107 18,089 -962 -5.05 67 28.85 0.0001
2025-05-08 2025-03-31 13F TERNS PHARMACEUTICALS COM 880881107 19,051 -4,770 -20.02 53 -60.31 0.0001
2025-02-14 2024-12-31 13F TERNS PHARMACEUTICALS COM 880881107 23,821 8,784 58.42 132 4.80 0.0003
2024-11-14 2024-09-30 13F TERNS PHARMACEUTICALS COM 880881107 15,037 15,037 125 0.0003
2024-08-13 2024-06-30 13F TERNS PHARMACEUTICALS COM 880881107 0 -12,121 -100.00 0 -100.00
2024-05-08 2024-03-31 13F TERNS PHARMACEUTICALS COM 880881107 12,121 1,079 9.77 80 11.27 0.0002
2024-02-14 2023-12-31 13F TERNS PHARMACEUTICALS COM 880881107 11,042 11,042 72 0.0002
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.